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ORIGINAL ARTICLESkin Barrier Development Depends on
CGI-58 Protein Expression during
Late-Stage Keratinocyte Differentiation
Susanne Grond1,8, Franz P.W. Radner1,8, Thomas O. Eichmann1, Dagmar Kolb2, Gernot F. Grabner1,
Heimo Wolinski1,3, Robert Gruber4, Peter Hofer1, Christoph Heier1, Silvia Schauer5,6, Thomas Ru¨licke5,
Gerald Hoefler3,5,6, Matthias Schmuth4, Peter M. Elias7, Achim Lass1, Rudolf Zechner1 and
Guenter Haemmerle1Adipose triglyceride lipase (ATGL) and its coactivator comparative gene identification-58 (CGI-58) are limiting in
cellular triglyceride catabolism. Although ATGL deficiency is compatible with normal skin development, mice
globally lacking CGI-58 die postnatally and exhibit a severe epidermal permeability barrier defect, which may
originate from epidermal and/or peripheral changes in lipid and energy metabolism. Here, we show that
epidermis-specific disruption of CGI-58 is sufficient to provoke a defect in the formation of a functional cor-
neocyte lipid envelope linked to impaired u-O-acylceramide synthesis. As a result, epidermis-specific CGI-58-
deficient mice show severe skin dysfunction, arguing for a tissue autonomous cause of disease development.
Defective skin permeability barrier formation in global CGI-58-deficient mice could be reversed via transgenic
restoration of CGI-58 expression in differentiated but not basal keratinocytes suggesting that CGI-58 is essential
for lipid metabolism in suprabasal epidermal layers. The compatibility of ATGL deficiency with normal
epidermal function indicated that CGI-58 may stimulate an epidermal triglyceride lipase beyond ATGL required
for the adequate provision of fatty acids as a substrate for u-O-acylceramide synthesis. Pharmacological inhi-
bition of ATGL enzyme activity similarly reduced triglyceride-hydrolytic activities in wild-type and CGI-58
overexpressing epidermis implicating that CGI-58 participates in u-O-acylceramide biogenesis independent
of its role as a coactivator of epidermal triglyceride catabolism.
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deficiency is even more severe leading to premature
lethality soon after birth due to a defect in the transepidermal
barrier function of the skin (Radner et al., 2010, 2011). CGI-
58 is a cofactor required for the stimulation of the enzymatic
activity of adipose triglyceride lipase (ATGL), the rate-limiting
enzyme in the catabolism of intracellular triglyceride (TG)
deposits in most if not all organs of the body (Lass et al.,
2006, 2011; Zierler et al., 2014). Remarkably, humans and
mice harboring mutant ATGL alleles show normal skin
development and function indicating that CGI-58 possesses
an ATGL-independent role in the skin. The fact that CGI-58 is
critically required for the ATGL-mediated TG catabolism in
multiple organs of the body including liver, muscle, and ad-
ipose raised the question whether the skin barrier defect and
postnatal lethality of mice globally lacking CGI-58 (Cgi-58/)
solely originates from the lack of epidermal CGI-58 or from
changes in whole-body TG and energy homeostasis.
To investigate the epidermis-specific role of CGI-58 in skin
development, we disrupted CGI-58 expression exclusively in
keratinocytes and examined the consequences on epidermal
barrier formation and systemic lipid and energy homeostasis.
Moreover, we generated CGI-58-deficient mice solely
expressing CGI-58 in an early or late stage of keratinocyte
differentiation to unravel the temporal and spatial role of
CGI-58 in epidermal development. Finally, we examined
the role of CGI-58 in ATGL-dependent and -independentestigative Dermatology. This is an open access
-nc-nd/4.0/). www.jidonline.org 403
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404epidermal TG catabolism to address whether CGI-58 may
additionally activate a yet unknown epidermal TG lipase
required for efficient fatty acid (FA) supply as a substrate for
the synthesis of complex epidermal lipids.
RESULTS
Epidermal CGI-58 is a prerequisite for functional skin barrier
formation
To generate mice lacking CGI-58 exclusively in the
epidermis, we bred mice expressing the Cre recombinase
transgene under the control of the epidermis-specific human
keratin 14 (K14) promoter (Vasioukhin et al., 1999) with mice
homozygous for the Cgi-58-floxed allele (Cgi-58flox/flox)
(Zierler et al., 2013). Very similar to mice globally lacking
CGI-58, Cgi-58flox/flox mice heterozygous for the K14-Cre
recombinase transgene (Cgi-58epid/) died within 12 hours
after birth and exhibited a glossy tight skin (Figure 1a).
Western blotting experiments revealed that CGI-58
protein expression was not detectable in the epidermis of
Cgi-58epid/ mice, mildly reduced in the dermis, and un-
changed in liver, lung, and heart when compared with levels
in Cgi-58flox/flox controls (Supplementary Figure S1 online).
Reduced CGI-58 protein expression in the tongue is in
accordance with K14 expression in tongue epithelial cells
(Vasioukhin et al., 1999). Morphologically, newborn Cgi-
58epid/ mice were smaller and wet weight was reduced
(25%) compared with Cgi-58flox/flox littermates (Figure 1b).
Plasma energy substrates including FA, glycerol, TG, and
glucose were markedly decreased in Cgi-58epid/ mice
(ranging from 47% to 86%) compared with controls
(Table 1), which may derive from the absence of suckling in
newborn Cgi-58epid/ mice.
The skin ofCgi-58epid/mice exhibited intense penetration
of a toluidine blue solution characteristic for a severe defect in
the epidermal water permeability barrier (Figure 1c). Histo-
logical analyses of skin sections by light or transmission elec-
tron microscopy (TEM) revealed orthohyperkeratosis with a
strongly condensed stratum corneum (SC) and a relatively thin
layer of granular keratinocytes (Figure 1d and e). Consistent
with this ichthyosiform skin phenotype, degradation of cor-
neodesmosomes was decelerated in Cgi-58epid/ SC indica-
tive of an abnormal desquamation. In fact, TEM revealed
retained nonperipheral corneodesmosomes up to the upper SC
layers of Cgi-58epid/ epidermis (Figure 1f), which are nor-
mally degraded during corneocyte maturation (Ishida-
Yamamoto and Igawa 2014). Correspondingly, desmoglein 1,
a major extracellular component of corneodesmosomes, was
undetectable in the SC of control mice but preserved
throughout the SC of Cgi-58epid/ mice (Figure 1g).
Next, the expression and distribution of proteins repre-
sentative for basal or hyperproliferative keratinocytes were
examined by immunohistochemistry of skin sections. K6 was
massively stained in keratinocytes of the upper stratum spi-
nosum and stratum granulosum throughout the interfollicular
epidermis of Cgi-58epid/ mice (Figure 1h, upper panel)
compared with the unique localization of K6 to hair follicles
in Cgi-58flox/flox controls. K14 was exclusively present in the
basal and lower spinous epidermal layers of controls,
whereas the protein was more diffusely distributed reaching
keratinocytes of the upper stratum spinosum and stratumJournal of Investigative Dermatology (2017), Volume 137granulosum (Figure 1h, middle panel) in Cgi-58epid/ mice.
Expression of filaggrin (FLG), a marker for terminally differ-
entiated keratinocytes (Sandilands et al., 2009), was reduced
in Cgi-58epid/ epidermis compared with controls
(Figure 1h, lower panel), indicating a delay in keratinocyte
differentiation. The latter was in line with TEM findings,
revealing smaller proFLG containing F-granules in Cgi-
58epid/ granular keratinocytes (Figure 1e). Western blot
analysis of FLG protein expression further showed insufficient
proFLG processing with increased abundance of multimeric,
nonprocessed FLG units at the expense of active, monomeric
FLG in Cgi-58epid/ compared with Cgi-58flox/flox epidermis
(Figure 1i). In accordance with delayed keratinocyte differ-
entiation, protein expression of loricrin, the main constituent
of the cornified envelope (CE) expressed late during cornifi-
cation (Candi et al., 2005), was strongly decreased in
epidermal extracts of Cgi-58epid/ mice (Figure 1j, upper
panel). In contrast, protein expression of involucrin (IVL),
which is an early marker in CE formation, was only margin-
ally reduced (Figure 1j, lower panel). Taken together, these
findings demonstrate that similar to global CGI-58 deficiency,
epidermis-specific deletion of CGI-58 causes a defect in the
epidermal permeability barrier that is linked to abnormal
desquamation and delayed keratinocyte differentiation. Thus,
tissue autonomous alterations in epidermal keratinocyte
metabolism are causative for defective epidermal develop-
ment in global CGI-58-deficient mice.
CGI-58 is essential for embryonic skin barrier formation
Cgi-58epid/ (and Cgi-58/) mice show severe ichthyosis
already at birth indicating that CGI-58 is critically required
for prenatal skin barrier formation. Thus, we explored the role
of CGI-58 in embryonic skin development using both an
inward skin permeability assay that reveals first stages in skin
barrier formation (Hardman et al., 1998) and a gravimetric
measurement of the transepidermal water loss (TEWL)
(Hanley et al., 1996; Nolte et al., 1993). The epidermal
barrier forms late in embryogenesis starting at embryonic day
(E) 16.5 of gestational age (Hardman et al., 1998), which is in
accordance with the intensive toluidine blue staining of Cgi-
58flox/flox and Cgi-58epid/ embryos at E15.5 (Figure 2a). At
E16.5, both Cgi-58flox/flox and Cgi-58epid/ mice showed a
reduction in dorsal toluidine blue staining indicating the
initiation of barrier acquisition. At this stage, the extent of
TEWL was comparable between Cgi-58flox/flox and Cgi-
58epid/ skin explants (Figure 2b) despite the apparent lack
of CGI-58 in the epidermis (Figure 2c). Barrier function was
almost complete at E17.5 in Cgi-58flox/flox control mice as
evident from marginal toluidine blue staining and a drastic
reduction in TEWL values (88%). Curiously, Cgi-58epid/
mice also established a pronounced toluidine blue-resistant
barrier at E17.5 (Figure 2a) and exhibited functional proFLG
processing (Figure 2d), indicative of proper keratinocyte dif-
ferentiation at this stage. In line, TEWL levels markedly
decreased in E17.5 Cgi-58epid/ skin explants (60%), yet to
a lesser extent compared with Cgi-58flox/flox controls
(Figure 2b). Concomitant with a marked increase in covalently
bound u-hydroxy-ceramides (u-OH-Cer) (Figure 2e), TEWL
decreased to the level of neonates in E18.5 Cgi-58flox/flox
embryos (Figure 2b) indicating full barrier competence.
Figure 1. Defective skin permeability barrier and ichthyosis in Cgi-58epidL/L mice. (a) Phenotype, (b) body wet weight (n ¼ 10), and (c) skin permeability
barrier function analyzed by toluidine blue staining of newborn Cgi-58flox/flox and Cgi-58epid/mice. (d) Histology (hematoxylin and eosin staining; scale bar ¼
50 mm) and (e) transmission electron microscopy (TEM; scale bar ¼ 1 mm) show hyperkeratosis, smaller F-granules, and lipid droplets (arrows) throughout
the stratum corneum (SC) of Cgi-58epid/ mice. (f) Impaired degradation of corneodesmosomes (arrows) in Cgi-58epid/ mice as analyzed by TEM (scale
bar ¼ 1 mm). (g) Immunohistochemistry of desmoglein 1/2 (DSG1/2), (h) keratin 6 (K6), K14, and filaggrin (FLG) in skin sections of newborn Cgi-58flox/flox
and Cgi-58epid/ mice. Protein levels of (i) FLG or (j) loricrin (LOR) and involucrin (IVL) detected by western blot analysis using GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) as loading control. ***P < 0.001. CGI-58, comparative gene identification-58; SG, stratum granulosum.
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Table 1. Plasma energy metabolites of newborn
Cgi-58flox/flox and Cgi-58epidL/L mice1
Cgi-58flox/flox Cgi-58epidL/L
FA (mM) 0.57  0.12 0.21  0.08***
Glycerol (mg/dl) 39.36  17.67 5.37  2.68***
TG (mg/dl) 101.52  29.50 15.75  3.63***
Glucose (mg/dl) 52.80  9.95 27.89  7.61***
Abbreviations: FA, free fatty acid; TG, triglyceride.
1Plasma parameters were measured on average 10 h postpartum (n ¼ 13).
Data are shown as means  standard deviations and are representative for
three independent measurements.
***P < 0.001.
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in Cgi-58epid/ embryos at that stage (Figure 2e) paralleled by
high TEWL values (8.4-fold compared with Cgi-58flox/flox),
massive toluidine staining, and impaired proFLG processing
(Figure 2d). These findings suggest a defect in epidermal bar-
rier acquisition in CGI-58-deficient epidermis that is primarily
linked to abnormal corneocyte lipid envelope (CLE) formation.
Yet, barrier competence improved between E18.5 and birth in
Cgi-58epid/ neonates, albeit TEWL was still increased 4-fold
compared with Cgi-58flox/flox controls. Wet body weights of
Cgi-58epid/ embryos were comparable with Cgi-58flox/flox
littermates during different gestational ages but were reduced
(25%) after birth (Figure 2f), most likely the consequence of
rapid water loss and absence of suckling.
Epidermal barrier formation depends on CGI-58 expression
in suprabasal epidermal layers
Next, we investigated the temporal and spatial role of CGI-58
expression during keratinocyte differentiation and skin barrier
formation. We generated transgenic mice expressing CGI-58
either under the control of the human K14 or the IVL pro-
moter, which activates gene expression in basal (Vasioukhin
et al., 1999; Vassar et al., 1989) or differentiated keratino-
cytes (Carroll and Taichman 1992; Carroll et al., 1993),
respectively. Mice expressing the Cgi-58 transgene under the
control of the K14 promoter [Tg(K14-Cgi58)604Biat], subse-
quently designated K14C (Supplementary Figure S2a online),
were bred onto a CGI-58-deficient background to generate
mice that express CGI-58 exclusively in the basal epidermal
layer (Cgi-58//K14C). Cgi-58//K14C mice appeared
smaller, exhibited a shiny rigid skin (Figure 3a), and died
postnatally similar to Cgi-58/ and Cgi-58epid/ mice.
Western blot analysis confirmed epidermis-specific expres-
sion of CGI-58 (Supplementary Figure S2b). Nevertheless, the
epidermis of Cgi-58//K14C mice was strongly permeable
for toluidine blue (Figure 3b) and morphologically very
similar to that of Cgi-58/ and Cgi-58epid/ mice
(Figure 3c). Accordingly, restoration of CGI-58 expression
solely in basal keratinocytes is not sufficient for the estab-
lishment of a functional epidermal barrier.
Next, mice expressing the Cgi-58 transgene under the
control of the human IVL promoter [Tg(IVL-Cgi58)663Biat],
subsequently designated IVLC (Supplementary Figure S2c),
were bred onto the CGI-58-deficient background to generate
mice that express CGI-58 exclusively in suprabasal
epidermal layers (Cgi-58//IVLC). Notably, IVL promoter-Journal of Investigative Dermatology (2017), Volume 137driven CGI-58 expression rescued the lethal skin barrier
defect of Cgi-58/ mice, and mutant mice were phenotyp-
ically indistinguishable from wild-type (WT) littermates
(Figure 3d). This indicates that CGI-58 expression in supra-
basal epidermal layers is a prerequisite for the establishment
of a functional skin permeability barrier. In epidermal prep-
arations from Cgi-58//IVLC mice, CGI-58 protein levels
were 13-fold increased (Supplementary Figure S2d)
compared with that of WT mice, whereas in the dermis
(except one sample that was presumably contaminated
with epidermal proteins), brown adipose tissue, and heart
CGI-58 expression was absent (Supplementary Figure S2e).
Cgi-58//IVLC mice were protected from toluidine blue
staining (Figure 3e) arguing for a functional water perme-
ability barrier in these animals. The SC in Cgi-58//IVLC and
WT mice was similar and characterized by the typical basket
weave structure (Figure 3f). In contrast to Cgi-58/ and Cgi-
58epid/ mice, Cgi-58//IVLC transgenic mice survived the
suckling period and reached adulthood without apparent hair
or skin alterations (Figure 3g). Newborn Cgi-58//IVLCmice
were similar to WT mice in terms of body weight and size
(Figure 3h and i). Nonetheless, plasma concentrations of FA
(34%), glycerol (54%), TG (49%), and glucose (21%)
were reduced in Cgi-58//IVLC compared with WT mice
(Supplementary Table S1 online) but markedly higher than in
Cgi-58/ and Cgi-58epid/ mice (Table 1). Taken together,
these data demonstrate that CGI-58 function is essential
during late keratinocyte differentiation and the establishment
of a functional epidermal permeability barrier.
Epidermal loss of CGI-58 provokes TG deposition in the SC
involving impaired ATGL-mediated TG catabolism
Global CGI-58 deficiency significantly increases the
epidermal TG content, which is less pronounced in
ATGL-deficient mice (Radner et al., 2010). Previously, it has
been hypothesized that impaired generation of long chain
unsaturated FAs as a substrate for u-O-acylceramide (u-O-
AcylCer) synthesis may originate from the lack of CGI-58 as a
coactivator of an unknown epidermal TG lipase in Cgi-58/
mice and patients with NLSDI (Radner et al., 2010; Uchida
et al., 2010). Consistent with this hypothesis, the epidermis-
specific deletion of CGI-58 strongly increased epidermal TG
levels, whereas CGI-58 expression exclusively in suprabasal
epidermal layers ofCgi-58//IVLCmice did not interferewith
epidermal TG homeostasis (Figure 4a). Ultrastructural analysis
of the epidermis by TEM revealed the presence of lipid droplet
inclusions within corneocytes of Cgi-58epid/ mice
(Figures 1e and 4b), which is consistent with observations in
patients with NLSDI (Akiyama et al., 2003; Demerjian et al.,
2006). Furthermore, label-free coherent anti-Stokes Raman
scattering microscopy revealed numerous neutral lipid puncta
in the SC of Cgi-58epid/ mice, which was not observed in
Cgi-58flox/flox epidermal sections (Figure 4c). These findings
suggest that the impairment of epidermal but not global TG
metabolism causes lipid accumulation in CGI-58-deficient
mice (and patients with NLSDI).
The availability of a small molecule inhibitor of ATGL
activity (Atglistatin) (Mayer et al., 2013) allowed us to
examine whether CGI-58 stimulates epidermal TG catabo-
lism via an ATGL-independent TG hydrolase. We measured
Figure 2. Embryonic skin permeability barrier development in the absence of CGI-58. Skin permeability barrier function of Cgi-58epid/ and Cgi-58flox/flox
mice (a) assayed by toluidine blue staining between embryonic stages E15.5eE18.5, and (b) measured using a gravimetric TEWL assay at E16.5eE18.5, and
P0. (c) CGI-58 and (d) filaggrin (FLG) protein levels analyzed by western blotting at indicated gestational ages in epidermal extracts of Cgi-58epid/ and
Cgi-58flox/floxmice (loading control ¼GAPDH). (e) Levels of covalently bound u-hydroxy-ceramides (u-OH-Cer) were determined by UPLC/MS in E16.5, E17.5,
E18.5, and P0 epidermis from Cgi-58epid/ and Cgi-58flox/flox mice (n ¼ 4e6). (f) Body wet weight of Cgi-58epid/ and Cgi-58flox/flox mice during late
embryonic development (E15.5eE18.5) and shortly after birth (P0). Data are presented as means  SD and are representative for two independent experiments.
***P < 0.001. CGI-58, comparative gene identification-58; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MS, mass spectrometry; SD, standard
deviation; TEWL, transepidermal water loss; UPLC, ultra performance liquid chromatography.
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controls (Cgi-58flox/flox or WT mice), Cgi-58epid/, and
Cgi-58//IVLC mice in both the absence and presence of
recombinant CGI-58 and/or Atglistatin. TG-hydrolase activ-
ities were markedly reduced (55%) in epidermal prepara-
tions of Cgi-58epid/ compared with Cgi-58flox/flox mice and
the presence of recombinant CGI-58 significantly increased
the activities in samples of both genotypes (Figure 4d). In line
with the established role of CGI-58 as a lipolytic coactivator,
TG-hydrolytic activities of Cgi-58epid/ samples reached
levels comparable with Cgi-58flox/flox epidermal preparations
on addition of recombinant CGI-58. The addition of Atglis-
tatin completely abolished this CGI-58-mediated increase inTG-hydrolytic activity, indicating that the CGI-58 effect on
TG hydrolysis exclusively depends on ATGL. Notably, in the
presence of Atglistatin, substantial TG-hydrolytic activity was
measured in epidermal lysates of Cgi-58flox/flox and Cgi-
58epid/ mice, which is in line with the presence of several
potential epidermal TG-lipase(s) (Toulza et al., 2007). Based
on our results, it is very unlikely that these TG hydrolases
depend on CGI-58 as a coactivator.
Unlike epidermal CGI-58 disruption, transgenic epidermis-
specific overexpression of CGI-58 in Cgi-58//InvCmice led
to a 79% increase in TG-hydrolase activity in epidermal ly-
sates when compared with WT samples (Figure 4e). The
addition of recombinant CGI-58 to epidermal preparations ofwww.jidonline.org 407
Figure 3. Restoration of CGI-58 expression in differentiated but not basal keratinocytes rescues the lethal skin barrier defect of Cgi-58L/L mice. Phenotypic
characterization including gross appearance, skin permeability (assayed by toluidine blue penetration), and hematoxylin and eosin stain of skin sections
(scale bar ¼ 70 mm) of newborn (aec) Cgi-58//K14C and (def) Cgi-58//IVLC mice compared with WT. (g) Phenotypes of 12-week-old female WT and
Cgi-58//IVLC mice. (h) Body wet weight and (i) body length of newborn WT and Cgi-58//IVLC mice. CGI-58, comparative gene identification-58;
K, keratin; WT, wild type.
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epidermal extracts of transgenic Cgi-58//InvC mice.
Notably, inhibition of ATGL by Atglistatin reduced epidermal
TG-hydrolytic activities in Cgi-58//InvC mice to those
measured in Atglistatin-treated WT samples. This further
supports the conclusion that CGI-58 controls epidermal TG
catabolism exclusively via activating ATGL. To further verify
this assumption, we determined TG-hydrolase activities in
epidermal extracts of ATGL-deficient (Atgl/) mice in the
presence of recombinant CGI-58 and/or Atglistatin
(Figure 4f). Consistent with the conclusion that CGI-58 does
not activate a “non-ATGL” TG lipase, the presence of re-
combinant CGI-58 raised TG-hydrolytic activities in WT but
not in Atgl/ epidermal extracts.
Defective u-O-AcylCer formation is reversed in
Cgi-58L/L/IVLC mice
The water-resistant epidermal barrier is due to the unique ar-
chitecture of the SC including extracellular lipid bilayers
organized in between the CLEs of the corneocytes. To inves-
tigate the role of epidermal CGI-58 in the creation of the SC
lipid barrier, we first assessed the SC ultrastructure of
epidermis-specific CGI-58-deficient and control mice by TEM
using both osmium tetroxide and ruthenium tetroxideJournal of Investigative Dermatology (2017), Volume 137postfixation methods. Cgi-58epid/ epidermis revealed aber-
rant lamellar body internal structures, inhomogeneous
lamellar body secretion with entombed organelles in corneo-
cytes, and impaired postsecretory lipid processing, resulting in
disorganized lamellar bilayers as comparedwith the uniformly
organized lamellar bilayers in controls (Figure 5a). Further-
more, whereas Cgi-58flox/flox corneocytes were surrounded by
a lipid monolayer representing the CLE, this structure was
absent in the SC of Cgi-58epid/mice (Figure 5b). The CE was
present in both mouse models, albeit CE appeared slightly
thinner in Cgi-58epid/mice (Figure 5b). Thus, like in patients
with NLSDI (Uchida et al., 2010), abnormalities in SC extra-
cellular lipid structures affecting both lamellar bilayers and the
CLE might underlie the permeability barrier defect in
epidermis-specific CGI-58-deficient mice.
Next, we performed lipid analyses by HPLC/LSD and
UPLC/mass spectrometry of epidermal lipid preparations
derived from Cgi-58epid/ and Cgi-58flox/flox mice. Levels of
cholesterol, FAs, CerNS (representative for nonacylated
ceramides), and u-O-AcylCer, characteristic for extracellular
lamellar bilayers, were determined. Although concentrations
of cholesterol, FAs, and CerNS were not or only moderately
altered, levels of u-O-(18:2)AcylCer, the most prominent u-
O-AcylCer species in the epidermis, were drastically reduced
Figure 4. Epidermal TG accumulation in the absence of CGI-58 involves impaired ATGL-mediated TG catabolism in the epidermis. (a) TG contents of
epidermal lipid extracts derived from Cgi-58flox/flox, Cgi-58epid/, and Cgi-58//IVLC mice were quantified by HPLC/LSD. Skin sections of newborn Cgi-
58epid/ mice show (b) lipid droplets (arrows) throughout the stratum corneum (SC) as analyzed by TEM (scale bar ¼ 1 mm), and (c) numerous neutral lipid
puncta as detected by label-free coherent anti-Stokes Raman scattering (CARS) microscopy (scale bar ¼ 5 mm). Measurement of TG-hydrolase activities in
epidermal preparations derived from (d) Cgi-58epid/, (e) Cgi-58//IVLC, (f) Atgl/ mice, and respective control mice (Cgi-58flox/flox and WT, respectively) in
the absence and/or presence of recombinant CGI-58 and the ATGL-specific inhibitor Atglistatin (Ai), or a combination of both (n ¼ pool of 4e7). Values
represent means  SD and are representative for three independent measurements. *P< 0.05; **P < 0.01; ***P< 0.001. ATGL, adipose triglyceride lipase; CGI-
58, comparative gene identification-58; FA, fatty acid; LSD, light-scattering detection; SD, standard deviation; SG, stratum granulosum; TEM, transmission
electron microscopy; TG, triglyceride; WT, wild type.
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(Figure 5c). Analysis of these lipid species in isolated SC
preparations resulted in comparable results (data not shown).
Glucosylated u-O-AcylCer serve as essential precursors for
the covalent linkage of u-OH-Cer to CE proteins for the for-
mation of the CLE (Breiden and Sandhoff, 2014; Elias et al.,
2014; Rabionet et al., 2014; Uchida and Holleran, 2008).
Consistent with a marked reduction in glucosylated u-O-
AcylCer (88%) (Figure 5d), levels of covalently bound u-
OH-Cer as well as protein-bound ultralong chain FAs
(Figure 5e) were drastically reduced in the epidermis of Cgi-
58epid/ mice (60 and 75%, respectively). Importantly,
the marked decline in u-O-(18:2)Acyl(Glc)Cer levels
together with the prominent reduction in covalently bound
u-OH-Cer content was completely restored on IVL-driven
overexpression of the CGI-58 transgene (Figure 5f) in Cgi-
58//IVLC mice. In fact, CGI-58 overexpression led to
increased levels of u-O-(18:2)Acyl(Glc)Cer in Cgi-58//
IVLC (þ23%) or WT/IVLC (þ34%) compared with WT
mice, indicating that CGI-58 plays a prominent role in
the biosynthesis of u-O-(18:2)Acyl(Glc)Cer. This is in line
with strongly increased levels of free extractable u-OH-Cer
and their glucosylated derivatives (5.2- and 13.6-fold,
respectively) in Cgi-58epid/ epidermis (Figure 5g), which
both might serve as a substrate for u-acylation with linoleic
acid.DISCUSSION
In this study, we examined the temporal and spatial role of
epidermal CGI-58 in keratinocyte differentiation and the
formation of a functional skin barrier. We demonstrate that
epidermis-specific disruption of CGI-58 in basal keratino-
cytes and consequently in all epidermal layers provokes a
lethal skin barrier defect almost identical to that observed in
mice globally lacking CGI-58 (Radner et al., 2010).
Conversely, functional restoration of CGI-58 expression in
differentiated keratinocytes (Cgi-58//IVLC) was compatible
with normal skin barrier function and survival of newborn
Cgi-58/ mice. These findings suggest that the ichthyosiform
skin phenotype and systemic changes in TG and energy ho-
meostasis in newborn Cgi-58/ mice primarily originate
from the tissue-specific absence of CGI-58 in the epidermis.
This is in contrast to DGAT2-deficient mice, where the lethal
skin barrier defect does not predominantly evolve from
impaired epidermal TG metabolism (Stone et al., 2004). Yet,
it relates to mice lacking elongation of very long chain FA or
FA transport protein 4, which exhibit comparable skin barrier
abnormalities that can be rescued by expression of the
respective protein in suprabasal keratinocytes (McMahon
et al., 2011; Moulson et al., 2007). Both proteins are
involved in the synthesis of epidermis-specific ultralong
chain ceramides that essentially contribute to the SC lipid
barrier. In line with a critical role of CGI-58 in the syntheticwww.jidonline.org 409
Figure 5. Defective u-O-acylceramide and CLE formation caused by global CGI-58-deficiency is reversed on CGI-58 expression in the epidermis. (a)
Compared with uniformly organized lamellar bilayers in Cgi-58flox/flox, bilayers show nonlamellar domains (arrows) in Cgi-58epid/ mice. This can be ascribed
to aberrant lamellar body (LB) internal structures (arrowheads), inhomogeneous LB secretion with entombed organelles in corneocytes (asterisks), and impaired
postsecretory lipid processing (double arrows). TEM; ruthenium postfixation; scale bars ¼ 100 nm. (b) Absent corneocyte lipid envelopes (arrows) and slightly
thinner cornified envelopes (arrowheads) in Cgi-58epid/ compared with Cgi-58flox/flox epidermis. TEM; pretreatment with pyridine; scale bar ¼ 100 nm. Lipid
analyses were performed by HPLC/LSD (cholesterol) or UPLC/MS (FA, ceramides) of indicated epidermal lipid extracts. Levels of (c) cholesterol, FA, CerNS, and
u-O-(18:2)-AcylCer, of (d) u-O-(18:2)AcylGlcCer, and of (e) covalently bound u-OH-Cer and FA in Cgi-58epid/ and Cgi-58flox/flox epidermis. (f) u-O-(18:2)-
AcylCer, u-O-(18:2)AcylGlcCer, and covalently bound u-OH-Cer levels in WT, Cgi-58/, Cgi-58//IVLC, and WT/IVLC epidermis. (g) Levels of free u-OH-
Cer and their glucosylated derivatives in Cgi-58epid/ and Cgi-58flox/flox epidermis. Values represent means  SD (n ¼ 5) and are representative for three
independent measurements. *P < 0.05; ***P < 0.001. CGI-58, comparative gene identification-58; CLE, corneocyte lipid envelope; F, F-granule; FA, fatty acid;
LSD, light-scattering detection; MS, mass spectrometry; N, nucleus; u-O-(18:2)AcylGlcCer, glucosylated u-O-AcylCeramide; u-OH-Cer, u-hydroxy-ceramides;
SD, standard deviation; TEM, transmission electron microscopy; UPLC, ultra performance liquid chromatography; WT, wild type.
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atinocyte differentiation together with its predominant
expression in granular keratinocytes (Akiyama et al., 2008),
gain of CGI-58 function solely in basal keratinocytes (Cgi-
58//K14C) did not prevent defective skin barrier formation.
Although the absence of CGI-58 protein expression in stra-
tum granulosum could not be verified in Cgi-58//K14C
epidermis due to the unavailability of a CGI-58 antibody
suitable for immunohistochemistry, reliable conclusions may
be drawn from other mouse models applying K14 promoter-
driven transgene expression. A study by Merrill et al. (2001)
has shown that K14 promoter-driven expression of myc-
tagged Tcf3 or Lef1 was targeted to basal keratinocytes and
persisted in some suprabasal cells. In agreement with an
essential role of CGI-58 in late-stage keratinocyte differenti-
ation, levels of loricrin and monomeric processed FLG, as a
measure of advanced cornification (Candi et al., 2005;
Sandilands et al., 2009), were markedly reduced in Cgi-
58epid/ epidermis. Consistently, nonlateral corneodesmo-
somes persisted in outermost SC layers preventing shedding
of corneocytes further emphasizing a defect in the cornifi-
cation process. Similar abnormalities in late corneocyte
maturation were also reported in ceramide synthase 3, ATP-
binding cassette subfamily A, or glucosylceramide synthase
mutant mice (Amen et al., 2013; Jennemann et al., 2012; Zuo
et al., 2008), suggesting that these defects might generally
result from lipid barrier dysfunctions. This assumption was
further confirmed by the finding that proFLG processing was
initially functional at E17.5 even in the absence of CGI-58.
On the other hand, epidermal K6 expression, a marker for
actively proliferating cells, was significantly increased in Cgi-
58epid/ epidermis, which might relate to a general attempt
of the skin to counteract defective epidermal barrier forma-
tion via keratinocyte hyperproliferation (Elias et al., 2008).
In agreement with a previous report (Hardman et al., 1998),
we found that resistance toward dye penetration emerges
shortly before birth. Both barrier patterning and TEWL levels
were similar between Cgi-58epid/ and WT embryos at
E16.5, indicating that the initiation of embryonic barrier for-
mation occurs independently of epidermal CGI-58. Although
Cgi-58epid/ mice gained considerable barrier properties at
E17.5, further barrier acquisition was delayed and did not
progress to full barrier competence. This is in contrast to mice
with transglutaminase 1 deficiency, lacking CE and CLE,
resulting in the complete absence of barrier development
(Kuramoto et al., 2002). The late onset of barrier dysfunction
in CGI-58-deficient epidermis might reflect a unique role of
CGI-58 in epidermal lipid barrier formation. In fact, WT
embryos already exhibited an almost functional CLE at E18.5
characterized by a marked raise in ultralong chain ceramides
covalently attached to the CE, which is in accordance with a
study by Doering (2002). In parallel, Cgi-58epid/mice failed
to produce sufficient covalently bound u-OH-Cer (and u-O-
(18:2)AcylCer, data not shown) providing further evidence
that the skin barrier defect on CGI-58 deficiency is primarily
linked to defective u-O-AcylCer and CLE formation.
CGI-58 is an established coactivator of ATGL and the
absence of either CGI-58 or ATGL strongly impairs TG and
energy catabolism in multiple organs (Haemmerle et al.,
2006; Lord and Brown, 2012; Zierler et al., 2014). Normalskin development of ATGL-deficient mice has led to the
notion that CGI-58 could coactivate a yet unknown
epidermal TG hydrolase required for adequate FA supply as
energy fuel and/or substrate for the generation of complex
epidermal lipids (Radner et al., 2010; Uchida et al., 2010).
Experiments with the recently developed ATGL inhibitor
Atglistatin (Mayer et al., 2013) argue against this hypothesis.
Although merely 30% of the total TG-hydrolase activity was
inhibited by Atglistatin and therefore attributable to ATGL,
the remaining 70% of “non-ATGL” TG-hydrolase activity
was not affected by the presence or absence of CGI-58. Thus,
it is unlikely that CGI-58 acts as a coactivator of an
epidermal TG lipase other than ATGL. Because ATGL defi-
ciency can be fully compensated by other epidermal lipases
and lack of ATGL does not impact epidermal u-O-AcylCer
levels, it may be concluded that the provision of FA from TG
for u-O-AcylCer formation is redundant and that
CGI-58-stimulated FA release is not limiting in this process.
u-O-Acyl(Glc)Cer as integral constituents of extracellular
lamellar bilayers and obligatory precursors for CLE formation
(Breiden and Sandhoff, 2014; Elias et al., 2014; Rabionet et al.,
2014; Uchida and Holleran, 2008) are indispensable for
epidermal permeability barrier function. Their biosynthesis
requires multiple enzymatic steps most of which are unique to
the epidermis and limiting for epidermal barrier formation, as
evidenced by the phenotype of mice lacking one of the
respective enzymes (Breiden and Sandhoff, 2014; Rabionet
et al., 2014). A common feature of these mouse models is
the absence of covalently bound u-OH-Cer. The very low
levels ofu-O-Acyl(Glc)Cer and subsequently the deficient CLE
in Cgi-58epid/ mice implicate that CGI-58 is critically
involved in the generation of these lipid classes and confirms
previous reports (Radner et al., 2010; Uchida et al., 2010).
Importantly, Cgi-58epid/ epidermis accumulates both glu-
cosylated and nonglucosylated freeu-OH-Cer, which is so far
unique as compared with other mouse models affecting the
synthesis of epidermis-specific ultralong chain ceramides.
Furthermore, we show that overexpression of CGI-58 in the
epidermis increases levels of u-O-Acyl(Glc)Cer. These find-
ings strongly suggest that CGI-58 actively participates in the
acylation of u-OH-Cer to generate u-O-Acyl(Glc)Cer.
Whether CGI-58 exhibits acyltransferase activity (Ghosh
et al., 2008; Khatib et al., 2016; McMahon et al., 2014;
Montero-Moran et al., 2010) is controversial. Extensive exper-
iments in our laboratory have not provided any evidence for
an enzymatic activity of CGI-58 to catalyze the transfer of
linoleic acid onto u-OH-Cer. Alternatively, it is conceivable
that CGI-58 acts as a coactivator tomediate acylation ofu-OH-
Cer by a currently unknown acyltransferase. Indeed, low levels
of covalently boundu-OH-Cer are present in CGI-58-deficient
epidermis suggesting that the formation of the CLE is not
entirelyabsent but rather highly inefficient.However, following
the protocol of Takagi et al. (2004), wewere unable tomeasure
u-acylation activity when epidermal preparations of WT and
CGI-58-deficient mice were incubated with u-OH-C30:0-
ceramide and radioactive linoleoyl-CoA. We assume that
either the epidermal u-acylation activity is too low to be
detectable in our assay system or that linoleoyl-CoA is not the
appropriate acyl-group donor in this reaction. It is conceivable,
for example, that linoleic acid is transferred to u-OH-Cer via awww.jidonline.org 411
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412transacylation reaction from a linoleate-containing epidermal
lipid species (e.g., TG and/or glycerophospholipids).
To summarize, we show that u-O-AcylCer and CLE for-
mation critically depend on CGI-58 expression in differenti-
ated keratinocytes. Furthermore, we deliver several lines of
evidence that the availability of epidermal CGI-58 is a pre-
requisite for the formation of u-O-Acyl(Glc)Cer, which is
independent of the role of CGI-58 as a coactivator of
epidermal and nonepidermal TG catabolism.
MATERIALS AND METHODS
Animals
Cgi-58epid/ mice were generated by breeding Cgi-58 floxed mice
(Radner et al., 2010; Zierler et al., 2013) with transgenic mice
expressing K14-driven Cre recombinase (Vasioukhin et al., 1999).
For transgene constructs, murine Cgi-58 cDNA was cloned down-
stream of the human K14 (Vassar et al., 1989) or IVL promoter
(Carroll et al., 1993; Carroll and Taichman, 1992) thereby replacing
the Cre recombinase or the galactosidase insert, respectively. Primer
sequences used for cloning are listed in Supplementary Table S2
online. Microinjections were performed according to a standard
protocol. All animal studies were approved by the Austrian Federal
Ministry for Science and Research and by the ethics committee of
the University of Graz and of the University of Veterinary Medicine
Vienna.
Plasma parameters
Blood sampling and measurement of plasma parameters were per-
formed as described previously (Radner et al., 2010).
Lipid analyses and in vitro TG-hydrolase activity assays
Procedures are described in the Supplementary Materials and
Methods online.
Western blot analysis
Western blots were performed according to standard protocols
applying commercially available antibodies listed in Supplementary
Table S3 online.
Skin permeation, gravimetric TEWL assay, histology,
immunohistochemistry, and TEM
Methods are described in the Supplementary Materials and
Methods.
Coherent anti-Stokes Raman scattering microscopy
Paraformaldehyde-fixed cryo sections (10 mm) of skin samples from
newborn mice were used to visualize neutral lipids by coherent anti-
Stokes Raman scattering microscopy as described in the
Supplementary Materials and Methods.
Statistics
Statistical analysis was performed using the unpaired two-tailed
Student’s t-test.
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